U.S., May 16 -- ClinicalTrials.gov registry received information related to the study (NCT06974266) titled 'An Efficacy and Safety Study of Akkermansia Muciniphila AKM Lab-01 in Hypercholesterolaemia' on April 14.
Brief Summary: The purpose of this study was to assess the safety and efficacy of AKM Lab-01 in subjects with hypercholesterolemia. This study will be conducted as a randomized, double-blind, placebo-controlled trial, eligible hypercholesterolemic participants were administered daily oral doses of either AKM Lab-01 or a placebo. Baseline clinical parameters, blood samples, and stool specimens were collected before and after the intervention for comparative analysis.
Study Start Date: June 10
Study Type: INTERVENTIONAL
Conditio...